Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Purchase(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-13 Sale(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Purchase | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Sale | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-10 Sale | 2024-12-11 7:56 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 16,393 | $9.0255 | $147,956 | 886,168 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:56 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 26,066 | $9.0124 | $234,916 | 766,010 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:54 pm | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 27,805 | $9.0076 | $250,456 | 115,509 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:53 pm | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 35,159 | $9.0077 | $316,703 | 543,549 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 109,502 | $9.0077 | $986,365 | 241,662 (Direct) | View |
| 2024-06-04 Sale(A) | 2024-11-26 4:48 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-08-01 Sale | 2024-08-05 4:30 pm | Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 2,400,000 | $14.91 | $35,796,000 | 783,118 (Indirect) | View |
| 2024-07-29 Sale | 2024-07-31 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $15.57 | $77,872 | 873,311 (Indirect Direct) | View |
| 2024-07-11 Sale | 2024-07-12 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $12.26 | $61,300 | 878,311 (Indirect Direct) | View |
| 2024-06-28 Sale | 2024-07-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.77 | $215,400 | 883,311 (Indirect Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:01 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-05-31 Sale | 2024-06-04 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $10.3 | $257,450 | 903,311 (Indirect Direct) | View |
| 2024-05-06 Sale | 2024-05-07 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $10.92 | $54,600 | 928,311 (Indirect Direct) | View |
| 2024-04-30 Sale | 2024-05-02 5:09 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $9.51 | $142,650 | 933,311 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-03-29 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.97 | $219,400 | 948,311 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.79 | $383,550 | 993,311 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Exercise | 2024-12-17 7:29 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,000 | $0 | 242,349 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-17 7:29 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,000 | $4.87 | 242,349 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:56 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 29,250 | $0 | 886,168 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:56 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 48,750 | $0 | 766,010 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:54 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 52,000 | $0 | 115,509 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:53 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 68,250 | $0 | 543,549 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:52 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 204,750 | $0 | 241,662 (Direct) | View |
| 2024-12-04 Disposition | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 3,369,704 | $0 | 9,826,972 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 3,369,704 | $0 | 9,826,972 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2,465,178 | $9.0799 | 9,826,972 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-18 06:00 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. | 25,000 | $0 | 672,458 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-18 06:00 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. | 25,000 | $7.02 | 672,458 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:31 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 23,000 | $0 | 9,049,293 (Indirect) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $0 | 216,664 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $4.87 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $0 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $4.87 | 216,664 (Direct) | View |
| 2024-03-05 Other | 2024-03-06 5:36 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 866,979 | $0 | 1,252,944 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 304,500 | $0 | 304,500 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 621,500 | $0 | 621,500 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $0 | 280,664 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $7.02 | 280,664 (Direct) | View |